1. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion;Rosenfeld;Ophthalmic Surg Lasers Imaging,2005
2. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration;Rosenfeld;Ophthalmic Surg Lasers Imaging,2005
3. Genentech press release. Phase III study shows Lucentis improved vision in patients with wet age-related macular degeneration. Available at: http://www.gene.com/gene/news/press-releases/display.do?method=detail&id=8727. Accessed: March 12, 2006.
4. Genentech press release. Preliminary phase III data from head-to-head study of Lucentis shows Lucentis improved vision compared to visudyne in patients with wet age-related macular degeneration. http://www.gene.com/gene/news/press-releases/display.do?method=detail&id=9307. Accessed March 2, 2006.
5. Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema;Mason;Retina,2006